Salt Lake City, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. (“IONIQ” or the “Company”), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our ‘breakthrough’ bioimpedance technology in breast cancer. “Skin Electrical Resistance as a Diagnostic […]
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division. […]
For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award. […]
Renalytix reported financial results for the quarter ended September 30, 2021. […]
The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery […]
Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.
[…]
Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD). […]
Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve. […]
Collaboration Expands Clinical Sites for Trial […]
NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS […]
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry […]
IONIQ Sciences Proudly Announces that Mrs. Jan Poulsen is a Lung Cancer Hero […]